Cargando…

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns

Health impacts of Mycobacterium tuberculosis (Mtb) and SARS-CoV-2 co-infections are not fully understood. Both pathogens modulate host responses and induce immunopathology with extensive lung damage. With a quarter of the world’s population harboring latent TB, exploring the relationship between SAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiok, Kim R., Dhar, Neeraj, Banerjee, Arinjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082467/ https://www.ncbi.nlm.nih.gov/pubmed/37091987 http://dx.doi.org/10.1016/j.isci.2023.106629

Ejemplares similares

SARS-CoV-2 variants of concern: the knowns and unknowns
por: Lessells, Richard J.
Publicado: (2021)

SARS-CoV-2 and the reproductive system: known and the unknown..!!
por: Sharma, Indu, et al.
Publicado: (2021)

SARS-CoV-2 and Zoonotic Preparedness: Unknown Knowns?
por: Irving, Aaron Trent, et al.
Publicado: (2021)

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
por: Zellweger, Raphaël M., et al.
Publicado: (2020)

SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
por: Redondo, Natalia, et al.
Publicado: (2021)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Virus hunters: Discovering the evolutionary origins of SARS-CoV-2
por: Banerjee, Arinjay
Publicado: (2021)

Molecular Determinants of SARS-CoV-2 Variants
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Clash of the titans: interferons and SARS-CoV-2
por: Jouvenet, Nolwenn, et al.
Publicado: (2021)

Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns
por: Silva, Marta L., et al.
Publicado: (2022)

Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

SARS‐CoV‐2, HIV, and Mycobacterium tuberculosis triple co‐infection
por: Ngouanom Kuate, Marius Paulin, et al.
Publicado: (2022)

Unraveling the Zoonotic Origin and Transmission of SARS-CoV-2
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations
por: Banerjee, Arinjay, et al.
Publicado: (2021)

Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization
por: Woods, J. Andrew
Publicado: (2021)

Evolutionary trajectory of SARS-CoV-2 and emerging variants
por: Singh, Jalen, et al.
Publicado: (2021)

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2
por: Mejia, Oscar Rosas, et al.
Publicado: (2021)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
por: Sessa, Francesco, et al.
Publicado: (2021)

Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review
por: Bostanghadiri, Narjess, et al.
Publicado: (2022)

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
por: Booysen, Petro, et al.
Publicado: (2023)

Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
por: Mouliou, Dimitra S., et al.
Publicado: (2022)

Proinflammatory responses in SARS-CoV-2 infected and soluble spike glycoprotein S1 subunit activated human macrophages
por: Chiok, Kim, et al.
Publicado: (2021)

Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of Mycobacterium tuberculosis and SARS-CoV-2
por: Peng, Cong, et al.
Publicado: (2023)

Aspergillus-SARS-CoV-2 Coinfection: What Is Known?
por: Castro-Fuentes, Carlos Alberto, et al.
Publicado: (2022)

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises
por: Satapathy, Prakasini, et al.
Publicado: (2022)

Versatile use of bat ACE2 for cellular entry by MERS-CoV-like viruses
por: Baid, Kaushal, et al.
Publicado: (2023)

The known knowns, known unknowns, and unknown unknowns of surveys and sleep
por: Shaker, Marcus, et al.
Publicado: (2022)

SARS-CoV-2 Infection: What Is Currently Known about Homocysteine Involvement?
por: Filip, Nina, et al.
Publicado: (2022)

Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages
por: Chiok, Kim, et al.
Publicado: (2023)

Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2
por: Rosas Mejia, Oscar, et al.
Publicado: (2022)

Genotyping SARS-CoV-2 through an interactive web application
por: Maan, Hassaan, et al.
Publicado: (2020)

Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns
por: Peng, Jinmin, et al.
Publicado: (2010)

Children’s SARS-CoV-2 Infection and Their Vaccination
por: Gupta, Sneh Lata, et al.
Publicado: (2023)

What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

Known unknowns and unknown unknowns
por: Burki, Talha
Publicado: (2018)

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
por: Baker, Paul J., et al.
Publicado: (2023)

Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism
por: Hoskisson, Paul A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d70t0h791j13vbgf618ffnucat